Aging, Blood Sugar; High, Inflammation, Muscle Loss, Muscle Weakness
Conditions
Brief summary
The elderly population have and increased risk of loss of both muscle mass and function and is therefore recommended a higher protein intake than the healthy adult population. These age-related changes in muscle function may be explained by chronic low-grade inflammation and insulin resistance. Despite the recommendation of a higher protein intake, little is known about how different protein sources may affect the metabolic health in this population. Analysis of amino acid composition show that fish can be a good protein source for humans. Many fish species are today used as feed ingredients, rather than a protein source for humans. A few studies conducted in humans and rats show that proteins from fish may improve glucose tolerance, reduce inflammation and improve lipid metabolism, indicating that proteins from fish may not only serve as a valuable nutrient but could also hold specific health promoting properties. The present study will investigate the effects of a protein hydrolysate from blue whiting, a fish species normally used to produce fish meal for aquaculture industry, on glucose homeostasis, inflammation and serum lipids in elderly nursing home residents.
Detailed description
Participants receive 6g per day of protein hydrolysate from blue whiting as protein powder mixed with a non-caloric juice for 6 weeks.
Interventions
Dietary Supplement: Blue whiting protein hydrolysate 6g protein per day for 6wk
Control group will receive non-caloric juice without protein supplementation
Sponsors
Study design
Eligibility
Inclusion criteria
* \>60 years * both genders * nursing home resident
Exclusion criteria
* life expectancy \< 6 months * severe cognitive impairment * allergies towards fish, milk, egg * weight loss \>5% last 3 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Participant compliance | 6 weeks | Investigate the participant compliance based daily registrations by nursing home staff |
| Participant dropout rate | 6 weeks | Number of participants that completed the intervention period |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| C-reactive protein in serum | 6 weeks | C-reactive protein (a marker of inflammation) will be analysed in fasting serum |
| Glucose regulation | 6 weeks | Glucose concentration will be measured in fasting serum |
| Monocyte chemoattractant protein-1 in serum | 6 weeks | Monocyte chemoattractant protein-1 (a marker of inflammation) will be analysed in fasting serum |
| Interleukin-6 in serum | 6 weeks | Interleukin-6 (a marker of inflammation) will be analysed in fasting serum |
| Insulin | 6 weeks | Insulin will be measured in fasting serum/plasma |